These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease. Giustina A, Bossoni S, Bussi AR, Pozzi A, Wehrenberg WB. Endocr Res; 1993 Mar; 19(1):47-56. PubMed ID: 7681769 [Abstract] [Full Text] [Related]
25. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F. J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314 [Abstract] [Full Text] [Related]
26. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus. Micić D, Macut D, Popović V, Kendereski A, Sumarac-Dumanović M, Zorić S, Dieguez C, Casanueva FF. Metabolism; 1999 Apr; 48(4):525-30. PubMed ID: 10206449 [Abstract] [Full Text] [Related]
27. Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog. Muruais J, Peñalva A, Dieguez C, Casanueva FF. J Endocrinol; 1993 Aug; 138(2):211-8. PubMed ID: 8228729 [Abstract] [Full Text] [Related]
30. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on growth hormone (GH) responses to GH-releasing hormone in patients with Cushing's syndrome. Leal-Cerro A, Pereira JL, Garcia-Luna PP, Astorga R, Cordido F, Casanueva FF, Dieguez C. Clin Endocrinol (Oxf); 1990 Aug; 33(2):291-5. PubMed ID: 2225484 [Abstract] [Full Text] [Related]